Search Results - "Sharaf El Din, Usama A.A."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review by Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.

    Published in Journal of advanced research (01-09-2017)
    “…[Display omitted] The association between uric acid (UA) on one side and systemic hypertension (Htn), dyslipidemia, glucose intolerance, overweight, fatty…”
    Get full text
    Journal Article
  2. 2

    Diabetic nephropathy: Time to withhold development and progression - A review by Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.

    Published in Journal of advanced research (01-07-2017)
    “…[Display omitted] The recent discoveries in the fields of pathogenesis and management of diabetic nephropathy have revolutionized the knowledge about this…”
    Get full text
    Journal Article
  3. 3

    Vitamin D deficiency: an unrecognized cause of flank pain by Abdulazim, Dina O., Salem, Mona M., Hassan, Mohammed, Abdo, Ahmed, Rashad, Esam, Sharaf El Din, Usama A. A.

    Published in Journal of bone and mineral metabolism (01-09-2018)
    “…Loin pain is frequently not associated with any urinary abnormality. Musculoskeletal abnormalities are not uncommon as alternative cause of flank pain…”
    Get full text
    Journal Article
  4. 4

    Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review by Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.

    Published in Journal of advanced research (01-05-2017)
    “…[Display omitted] The death rate among chronic kidney disease patients is the highest compared to other chronic diseases. 60% of these fatalities are…”
    Get full text
    Journal Article
  5. 5

    Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients by Fayed, Ahmed, El Nokeety, Mahmoud M., Heikal, Ahmed A., Abdulazim, Dina O., Naguib, Mervat M., Sharaf El Din, Usama A. A.

    Published in Renal failure (01-11-2018)
    “…Insulin resistance (IR) is very common among chronic kidney disease (CKD) patients. Disturbance in mineral and bone metabolism (MBD) seems to play a role in…”
    Get full text
    Journal Article
  6. 6

    The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers by NasrAllah, Mohamed M., El-Shehaby, Amal R., Osman, Noha A., Fayad, Tarek, Nassef, Amr, Salem, Mona M., Sharaf El Din, Usama A.A.

    Published in Nephron extra (06-11-2013)
    “…Background: Fibroblast growth factor-23 (FGF-23) has been linked to vascular calcification, ventricular hypertrophy and mortality in chronic kidney disease…”
    Get full text
    Journal Article
  7. 7

    Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients by NasrAllah, Mohamed M., El-Shehaby, Amal R., Osman, Noha A., Salem, Mona M., Nassef, Amr, El Din, Usama A. A. Sharaf

    Published in International urology and nephrology (01-08-2012)
    “…Background Advanced glycation end-products (AGE) accumulate in CKD and may predispose to cardiovascular disease by inducing inflammatory and oxidant stress in…”
    Get full text
    Journal Article
  8. 8

    Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action by Zayed, Bahaa Eldin, El-Fishawy, Hussein, Al-Shihaby, Amal R., Salem, Mohamed A., Sharaf El Din, Usama A. A., Mansour, Mona

    Published in The Egyptian journal of internal medicine (01-10-2015)
    “…Background The non-calcium-based phosphate binder sevelamer hydrochloride was developed to provide chronic kidney disease patients with a polymer capable of…”
    Get full text
    Journal Article
  9. 9